Skip to main content
Premium Trial:

Request an Annual Quote

Sankyo of Japan Signs Up for Gene Logic Databases

NEW YORK, April 2 - Gene Logic said Monday it had signed Sankyo, Japan’s second-largest pharmaceutical company, as a subscriber to its BioExpress and ToxExpress databases, bringing the total number of subscribers to 16.

Gene Logic did not disclose financial terms of the deal except to say that Sankyo had acquired the right to use the company’s databases and visualization tools throughout its research and development division.

The Gaithersburg, Md.-based database company has previously said that subscriptions to its individual databases such as BioExpress and ToxExpress generally go for $1.5 million a year and terms are usually for three years.

Sankyo said it would use the databases to search for new genes that could be used to develop new treatments.

"Our goal is to identify novel genes that have the potential to lead to innovative new compounds for the treatment of major diseases and disorders throughout the world. We believe Gene Logic's GeneExpress Suite can help to accelerate the process of identifying new genes for pharmaceutical development,” Sankyo said in a statement. 

Gene Logic’s BioExpress database contains gene expression data on normal and diseased human tissues, tissues from model animal systems, and human and animal cell lines for use in target identification and target validation studies. ToxExpress is a reference library of toxicity markers derived from examination of known toxic compounds in rodent model systems and across human and rat primary cell lines.

Amersham Pharmacia Biotech is Gene Logic’s sales and marketing partner in Japan.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.